Abstract

Nevoid basal cell carcinoma syndrome (NBCCS) is a tumor predisposition condition, the cardinal features of which emerge in adolescence or adulthood. Using statistical optimization, this study proposes NBCCS criteria with improved sensitivity in children less than 18 years of age. Earlier detection may lead to improved surveillance and prevention of sequelae. A survey eliciting medical history was completed by, or on behalf of, individuals with NBCCS. Based on these findings, criteria for suspicion of NBCCS in children were suggested using information from a Bernoulli naïve Bayes classifier relying on the human phenotype ontology. The sensitivity and specificity of the existing and proposed diagnostic criteria were also assessed. Participants (n = 48) reported their first signs of NBCCS appeared at a median age of 8 months, but by our retrospective analysis, they did not fulfill the current diagnostic criteria until a median age of 7 years. This study delineates the early-onset features of NBCCS and proposes criteria that should prompt consideration of NBCCS. Additionally, we demonstrate a method for quantitatively assessing the utility of diagnostic criteria for genetic disorders.

Details

Title
Proposed criteria for nevoid basal cell carcinoma syndrome in children assessed using statistical optimization
Author
Gold, Nina B 1   VIAFID ORCID Logo  ; Campbell, Ian M 2 ; Sheppard, Sarah E 3 ; Wen-Hann, Tan 4 

 Massachusetts General Hospital for Children, Division of Medical Genetics and Metabolism, Harvard Medical School, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924) 
 Children’s Hospital of Philadelphia, Division of Human Genetics, Philadelphia, USA (GRID:grid.239552.a) (ISNI:0000 0001 0680 8770); Children’s Hospital of Philadelphia, Department of Biomedical and Health Informatics, Philadelphia, USA (GRID:grid.239552.a) (ISNI:0000 0001 0680 8770) 
 Children’s Hospital of Philadelphia, Division of Human Genetics, Philadelphia, USA (GRID:grid.239552.a) (ISNI:0000 0001 0680 8770) 
 Boston Children’s Hospital, Harvard Medical School, Division of Genetics and Genomics, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2579207001
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.